Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance to such therapies frequently ensues. A significant subset of patients with resistant disease develop AR-negative tumors that l...

Descripción completa

Detalles Bibliográficos
Autores principales: Brady, Nicholas J., Bagadion, Alyssa M., Singh, Richa, Conteduca, Vincenza, Van Emmenis, Lucie, Arceci, Elisa, Pakula, Hubert, Carelli, Ryan, Khani, Francesca, Bakht, Martin, Sigouros, Michael, Bareja, Rohan, Sboner, Andrea, Elemento, Olivier, Tagawa, Scott, Nanus, David M., Loda, Massimo, Beltran, Himisha, Robinson, Brian, Rickman, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185096/
https://www.ncbi.nlm.nih.gov/pubmed/34099734
http://dx.doi.org/10.1038/s41467-021-23780-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185096/
https://www.ncbi.nlm.nih.gov/pubmed/34099734
http://dx.doi.org/10.1038/s41467-021-23780-y

Ejemplares similares